1 序文
2 範囲と方法論
2.1 本調査の目的
2.2 利害関係者
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法論
3 エグゼクティブサマリー
4 はじめに
4.1 概要
4.2 主要な業界動向
5 世界の外科用ドレッシング市場
5.1 市場概要
5.2 市場実績
5.3 COVID-19 の影響
5.4 市場予測
6 製品別市場内訳
6.1 一次ドレッシング
6.1.1 市場動向
6.1.2 主要セグメント
6.1.2.1 フィルムドレッシング
6.1.2.2 ハイドロゲルドレッシング
6.1.2.3 ハイドロコロイドドレッシング
6.1.2.4 フォームドレッシング
6.1.2.5 アルギネートドレッシング
6.1.2.6 その他
6.1.3 市場予測
6.2 二次ドレッシング
6.2.1 市場動向
6.2.2 主要セグメント
6.2.2.1 吸収剤
6.2.2.2 吸収剤
6.2.2.3 粘着テープ
6.2.2.4 保護材
6.2.2.5 その他
6.2.3 市場予測
6.3 その他
6.3.1 市場動向
6.3.2 市場予測
7 用途別市場規模
7.1 潰瘍
7.1.1 市場動向
7.1.2 市場予測
7.2 火傷
7.2.1 市場動向
7.2.2 市場予測
7.3 臓器移植
7.3.1 市場動向
7.3.2 市場予測
7.4 心臓血管疾患
7.4.1 市場動向
7.4.2 市場予測
7.5 糖尿病を原因とする手術
7.5.1 市場動向
7.5.2 市場予測
7.6 その他
7.6.1 市場動向
7.6.2 市場予測
8 エンドユーザー別市場
8.1 病院
8.1.1 市場動向
8.1.2 市場予測
8.2 専門クリニック
8.2.1 市場動向
8.2.2 市場予測
8.3 在宅医療
8.3.1 市場動向
8.3.2 市場予測
8.4 外来手術センター
8.4.1 市場動向
8.4.2 市場予測
8.5 その他
8.5.1 市場動向
8.5.2 市場予測
9 地域別市場規模
9.1 北米
9.1.1 米国
9.1.1.1 市場動向
9.1.1.2 市場予測
9.1.2 カナダ
9.1.2.1 市場動向
9.1.2.2 市場予測
9.2 アジア太平洋地域
9.2.1 中国
9.2.1.1 市場動向
9.2.1.2 市場予測
9.2.2 日本
9.2.2.1 市場動向
9.2.2.2 市場予測
9.2.3 インド
9.2.3.1 市場動向
9.2.3.2 市場予測
9.2.4 韓国
9.2.4.1 市場動向
9.2.4.2 市場予測
9.2.5 オーストラリア
9.2.5.1 市場動向
9.2.5.2 市場予測
9.2.6 インドネシア
9.2.6.1 市場動向
9.2.6.2 市場予測
9.2.7 その他
9.2.7.1 市場動向
9.2.7.2 市場予測
9.3 欧州
9.3.1 ドイツ
9.3.1.1 市場動向
9.3.1.2 市場予測
9.3.2 フランス
9.3.2.1 市場動向
9.3.2.2 市場予測
9.3.3 英国
9.3.3.1 市場動向
9.3.3.2 市場予測
9.3.4 イタリア
9.3.4.1 市場動向
9.3.4.2 市場予測
9.3.5 スペイン
9.3.5.1 市場動向
9.3.5.2 市場予測
9.3.6 ロシア
9.3.6.1 市場動向
9.3.6.2 市場予測
9.3.7 その他
9.3.7.1 市場動向
9.3.7.2 市場予測
9.4 ラテンアメリカ
9.4.1 ブラジル
9.4.1.1 市場動向
9.4.1.2 市場予測
9.4.2 メキシコ
9.4.2.1 市場動向
9.4.2.2 市場予測
9.4.3 その他
9.4.3.1 市場動向
9.4.3.2 市場予測
9.5 中東およびアフリカ
9.5.1 市場動向
9.5.2 国別の市場内訳
9.5.3 市場予測
10 推進要因、阻害要因、機会
10.1 概要
10.2 推進要因
10.3 阻害要因
10.4 機会
11 バリューチェーン分析
12 ポーターのファイブフォース分析
12.1 概要
12.2 買い手の交渉力
12.3 サプライヤーの交渉力
12.4 競争の度合い
12.5 新規参入の脅威
12.6 代替品の脅威
13 価格分析
14 競合状況
14.1 市場構造
14.2 主要企業
14.3 主要企業のプロフィール
14.3.1 3M 社
14.3.1.1 会社概要
14.3.1.2 製品ポートフォリオ
14.3.1.3 財務
14.3.1.4 SWOT分析
14.3.2 Advancis Medical
14.3.2.1 会社概要
14.3.2.2 製品ポートフォリオ
14.3.3 B. Braun Melsungen AG
14.3.3.1 会社概要
14.3.3.2 製品ポートフォリオ
14.3.4 カーディナルヘルス社
14.3.4.1 会社概要
14.3.4.2 製品ポートフォリオ
14.3.4.3 財務
14.3.4.4 SWOT分析
14.3.5 コロプラスト社
14.3.5.1 会社概要
14.3.5.2 製品ポートフォリオ
14.3.5.3 財務
14.3.5.4 SWOT分析
14.3.6 Convatec Group plc
14.3.6.1 会社概要
14.3.6.2 製品ポートフォリオ
14.3.6.3 財務
14.3.7 DeRoyal Industries Inc.
14.3.7.1 会社概要
14.3.7.2 製品ポートフォリオ
14.3.8 Molnlycke Health Care AB
14.3.8.1 会社概要
14.3.8.2 製品ポートフォリオ
14.3.8.3 SWOT分析
14.3.9 Paul Hartmann AG
14.3.9.1 会社概要
14.3.9.2 製品ポートフォリオ
14.3.9.3 財務
14.3.9.4 SWOT分析
14.3.10 Smith & Nephew Plc
14.3.10.1 会社概要
14.3.10.2 製品ポートフォリオ
14.3.10.3 財務
14.3.10.4 SWOT分析
Surgical dressing refers to any fibrous material that is used to provide protection to exposed tissues and keep wounds in a hygienic and proper manner. Usually made from fibres as well as fabrics, gauze, lint, and plasters, it is placed over a wound as a protective covering. Surgical dressings include sterile pads, compress, or composite waterproof multi-layered bandages, which are most commonly used as a wound covering. A surgical dressing, as opposed to a bandage, is formulated to be in direct contact with the wound, and most of them are self-adhesive. Three-layer surgical dressings contain semi- or non-adherent lower layers to infuse water into the following layer, while preventing it from sticking to the granulated tissue. In addition to protecting the wound from mechanical damage and absorbing drainage, surgical dressings protect the wound from contamination by bodily discharges, such as feces and urine, provide a physiologic environment conducive to healing, and offer mental and physical comfort for the patient.
Surgical Dressing Market Trends:
The growing prevalence of chronic wounds, ulcers, and burns across the globe is a significant factor that is driving the market. This can be attributed to the rising number of chronic health conditions as well as sedentary lifestyle and poor dietary patterns adopted by the masses. In line with this, a considerable rise in the uptake of organ transplant procedures, particularly knee and hip replacement surgeries requiring intensive care, is also providing an impetus to the market. Moreover, the expanding number of ambulatory surgery centers and specialty clinics for affordable outpatient procedures is creating lucrative growth opportunities in the market. The market is further fueled by the increasing incidences of road accidents, which is resulting in a higher uptake of surgical dressings. Besides this, the growing geriatric population that is more susceptible to chronic wounds and slower healing ability is creating a positive outlook for the market. Furthermore, continual technological developments in the treatment services involving surgical procedures and pain management are impacting the market positively. Favorable healthcare initiatives undertaken by the government bodies of several countries promoting affordability and sanitized facilities are also propelling the market. Some of the other factors contributing to the market include the rising healthcare expenditure, the augmenting popularity of minimally invasive surgeries, the increasing number of cardiovascular disease-related surgeries, and easy product availability across online and offline organized retail channels.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global surgical dressing market, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on product, application and end user.
Product Insights
Primary Dressing
Film Dressing
Hydrogel Dressing
Hydrocolloid Dressing
Foam Dressing
Alginate Dressing
Others
Secondary Dressing
Absorbents
Bandages
Adhesive Tapes
Protectives
Others
Others
The report has provided a detailed breakup and analysis of the surgical dressing market based on the product. this includes primary dressing (film, hydrogel, hydrocolloid, foam, alginate and other dressing), secondary dressing (absorbents, Bandages, adhesive tapes, protectives and others), and others. According to the report, primary dressing (film dressing, hydrogel dressing, hydrocolloid dressing, foam dressing, alginate dressing, and others) represented the largest segment.
Application Insights
Ulcers
Burns
Organ Transplants
Cardiovascular Disease
Diabetes Based Surgeries
Others
The report has provided a detailed breakup and analysis of the surgical dressing market based on the application. This includes ulcers, burns, organ transplants, cardiovascular disease, diabetes based surgeries and others. According to the report, diabetes based surgeries represented the largest segment.
End User Insights
Hospital
Specialty Clinics
Home Healthcare
Ambulatory Surgery Centers
Others
A detailed breakup and analysis of the surgical dressing market based on the end user has also been provided in the report. This includes hospital, specialty clinics, home healthcare, ambulatory surgery centers, and others. According to the report, hospital accounted for the largest market share.
Regional Insights
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for surgical dressing. Some of the factors driving the North America surgical dressing market include the increasing geriatric population, rising healthcare expenditure, expanding number of hospital chains and healthcare facilities etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global surgical dressing market. Detailed profiles of all major companies have also been provided. Some of the companies covered include 3M Company, Advancis Medical, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, Convatec Group plc, DeRoyal Industries Inc., Molnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew Plc, etc.
Key Questions Answered in This Report:
How has the global surgical dressing market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global surgical dressing market?
What are the key regional markets?
Which countries represent the most attractive surgical dressing markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What is the competitive structure of the global surgical dressing market?
Who are the key players/companies in the global surgical dressing market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Surgical Dressing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Primary Dressing
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Film Dressing
6.1.2.2 Hydrogel Dressing
6.1.2.3 Hydrocolloid Dressing
6.1.2.4 Foam Dressing
6.1.2.5 Alginate Dressing
6.1.2.6 Others
6.1.3 Market Forecast
6.2 Secondary Dressing
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Absorbents
6.2.2.2 Absorbents
6.2.2.3 Adhesive Tapes
6.2.2.4 Protectives
6.2.2.5 Others
6.2.3 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Ulcers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Burns
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Organ Transplants
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular Disease
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Diabetes Based Surgeries
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End User
8.1 Hospital
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Specialty Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Home Healthcare
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Ambulatory Surgery Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Advancis Medical
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 B. Braun Melsungen AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Cardinal Health Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Coloplast A/S
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Convatec Group plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 DeRoyal Industries Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Molnlycke Health Care AB
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Paul Hartmann AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Smith & Nephew Plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
*** 外科用ドレッシングの世界市場に関するよくある質問(FAQ) ***
・外科用ドレッシングの世界市場規模は？
→IMARC社は2024年の外科用ドレッシングの世界市場規模を47億米ドルと推定しています。
・外科用ドレッシングの世界市場予測は？
→IMARC社は2033年の外科用ドレッシングの世界市場規模を71億米ドルと予測しています。
・外科用ドレッシング市場の成長率は？
→IMARC社は外科用ドレッシングの世界市場が2025年～2033年に年平均4.6%成長すると展望しています。
・世界の外科用ドレッシング市場における主要プレイヤーは？
→「3M Company, Advancis Medical, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, Convatec Group plc, DeRoyal Industries Inc., Molnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew Plcなど ...」を外科用ドレッシング市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
